AT
Aclaris Therapeutics Inc
🇺🇸XNAS.ACRSUnited StatesHealthcare
$5.04USDdown -0.49 (-8.86%)OpenDelayed7:29 PM
Price$5.04-0.49 (-8.86%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00461U1051
- CUSIP
- 00461U105
Company
- Employees
- 69
- Headquarters
- Wayne, United States
- Website
- https://www.aclaristx.com
- CEO
- Dr. Neal S. Walker D.O., M.D.
Market
- Shares outstanding
- 147.2M
- Market cap
- $741.88M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $812.54M
- EPS LTM
- -$0.51calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -9.80calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $8.22M-51.05%down year on year
- Net income
- -$75.74M+43.75%up year on year
- Gross margin
- 95.61%+489.27%up year on year
- Free cash flow
- -$62.18M-33.16%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.